Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04656132 · ClinicalTrials.gov registry record · Phase 1
PAVS in Cardiology
A Phase 1 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 63
- Enrollment target
NCT04656132 is a Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 63 participants.
The verdict
NCT04656132, a Phase 1 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
Brief Summary This is a pilot study implemented physical activity assessment, promotion and monitoring in patients. Patients will be assessed by the physical activity vital sign (PAVS) during check-in for their appointment. During their visit with the cardiologist, a clinical decision support tool will alert the cardiologist to patients achieving low (\<50% of recommended) physical activity. The cardiologist may refer the patient to cardiac rehabilitation if appropriate and/or counsel them to increase their physical activity levels. The patients may opt to enroll in the monitoring phase of the study. They will be given a Fitbit pedometer and their Fitbit account can sync to their MyChart account. After that sync, the patients step counts will be available for their cardiologists to review as needed.
Interventions
- BEHAVIORAL Physical activity assessment, promotion and monitoring in a preventive cardiology clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2022-08-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04656132
The ClinicalTrials.gov registry entry for NCT04656132 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Physical activity assessment, promotion and monitoring in a preventive cardiology clinic is the first listed.
NCT04656132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04656132 about?
NCT04656132 is a clinical study titled "PAVS in Cardiology". Brief Summary This is a pilot study implemented physical activity assessment, promotion and monitoring in patients. Patients will be assessed by the physical activity vital sign (PAVS) during check-in for their appointment. During their visit with the cardiologist, a clinical decision support tool w...
What is the current status of trial NCT04656132?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 63 participants. The study started on 2021-07-14. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT04656132?
The interventions under investigation include: Physical activity assessment, promotion and monitoring in a preventive cardiology clinic (BEHAVIORAL).
Who is sponsoring clinical trial NCT04656132?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.